Sanifit, a clinical-stage biopharmaceutical company focused on treatments for progressive vascular calcification disorders that is part of Alta Life Sciences portfolio, has been named by FierceBiotech as one of 2019’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry. In June 2019 Sanifit announced the completion of a €72.2 million (USD 80.9 million) private fundraising to further accelerate the clinical development…
